A fracture-related infection (FRI) is an important complication that can lead to an increase in morbidity, mortality and economic costs. Preclinical in vivo models are critical in the evaluation of novel prevention and treatment strategies, yet it is important that these studies recapitulate the features of an FRI that make it such a clinical challenge. The aim of this systematic review was to survey the available preclinical models of FRIs and assess which of the key FRI-specific parameters are incorporated in these models.
Introduction
Fracture-related infections (FRIs) are among the most important complications after fracture fixation (Reizner et al., 2014) . The cause of this complication is often multifactorial, with the risk of infection being significantly higher, for example, in cases of an open fracture, severe soft tissue damage and polytrauma patients (Kortram et al., 2017) . Internal fixation of closed fractures has a relatively low infection incidence of 1-2 %, whilst the incidence after the operative treatment of open fractures can rise to 30 % (Boxma et al., 1996; Ktistakis et al., 2014; Papakostidis et al., 2011 ). An FRI can negatively affect the clinical outcome due to delayed healing, functional impairment or even amputation of the affected limb (Metsemakers et al., 2018a) . FRIs also lead to prolonged hospital stays, increased morbidity and mortality and are associated with higher healthcare and overall economic costs in comparison to non-infected equivalents (Olesen et al., 2017) .
Due to the negative impact of FRIs on the clinical outcome, and the associated socio-economic impact, a large amount of research is performed to optimise prevention and treatment strategies for FRIs (Metsemakers et al., 2018a) . Conducting clinical trials of FRIs in human subjects is a challenge due to the low infection incidence, the heterogeneity of the www.ecmjournal.org musculoskeletal trauma population, the multiplicity of treatment options and the broad range of possible causative bacteria (Reizner et al., 2014) . Therefore, preclinical in vivo models can serve as a critical control point prior to clinical application of any new diagnostic procedure or intervention, offering a controlled environment without many of the variables inherent in a patient population. To provide a robust evaluation of any intervention aiming to simulate an FRI, the chosen model should ideally recapitulate the clinical condition (Brown et al., 2014) . This includes a fracture creation, soft tissue damage, contamination with bacteria, and, when mimicking an open fracture situation, a delay in treatment (i.e. debridement and surgical fixation several hours after the traumatic incident).
The aim of the present systematic review was to survey the range and critical features of preclinical in vivo models used in FRI studies. The hypothesis was that these models only rarely include these key FRI factors.
Materials and Methods
All relevant aspects of the Cochrane Handbook for Interventional Systematic Reviews (Higgins and Green, 2011) were followed and the study was written according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Moher et al., 2010) .
Search strategy
A comprehensive search was performed on July 1 st 2017 in PubMed, Embase and Web of Science. With the help of a biomedical information specialist, a set of search strings were composed for each database. Overall, 1,208 references were collected in Mendeley (Mendeley desktop version 1.17.11, Elsevier) . After the exclusion of duplicates, 995 articles were retained. These were screened by two reviewers (NV and MM). In case the two reviewers did not reach consent, a third reviewer (WJM) was consulted.
The search process is summarised in Fig. 1 . During the first phase, titles and abstracts were reviewed. Irrelevant articles were excluded and 170 relevant articles were retained for full text review. After review of the full text of the remaining articles, 75 eligible articles were included in the present review.
Inclusion/exclusion criteria Inclusion criteria were (1) preclinical in vivo models, (2) presence of bony instability (a fracture/osteotomy/ defect) of long bones, (3) local inoculation of the In treatment studies, the tested intervention is mostly performed after an infection is allowed to develop over a certain time. Studies with the primary objective of studying the infection influence on bone healing or evaluating new strategies to improve callus formation in infected fractures were assigned to the bone healing group. Studies with the primary aim of investigating the microorganisms' characteristics (e.g. intracellular survival) and the fracture environment (e.g. increased perfusion of infected fractures) were labelled as pathogenesis. These studies also examined different patterns of infection and osteolysis.
Results

Study objective
Articles were categorised into five groups (model description, prevention study, treatment study, bone healing study and model on the pathogenesis of an FRI), based on the objective of the research (Table 1) (Table 1) .
Animal species
Eight different animal species are mentioned in the studies ( 
Anatomical location
An overview of the anatomical locations of instability creation is provided in Table 2 -4. In most of the included models, fractures, osteotomies or osseous defects are created in the lower limb (n = 65; 86.7 %), with relatively fewer utilising the upper limb (n = 10; 13.3 %). The anatomical area of choice is the femur in thirty-nine studies (52 %), the tibia in twenty-five (33.3 %), tibia and fibula in one (1.3 %), the humerus in three (4 %), the radius in five (6.7 %) and the ulna in two (2.7 %).
Model type
According to the previously mentioned definition, most models simulate a closed fracture situation (n = 63; 84 %), whereas only twelve (16 %) studies mimic an open fracture by introducing a time gap between inoculation and fixation (Table 2-4). Bone instability is applied by creating a fracture, an osteotomy or a defect. In nineteen (25.3 %) models (Table 2) , a real fracture is created. In most of the studies, this is established by using a specially designed device, in which a weight is dropped on the bone, causing a fracture that can be reproduced multiple times. Failure of this technique is mentioned only once: Boyce et al. (2012) report the exclusion of one animal because of a comminuted fracture not fixable with their implant system. Hill and Watkins (2001) describe a model in which a fracture is created by firing a steel fragment at the tibia. In the model of Petri and Schaberg (1984) , a fracture is created by using a rongeur. In thirty (40 %) models, a single osteotomy is performed to mimic a fracture ( Table  3) . A defect is created in twenty-six (34.7 %) models mostly by performing a double osteotomy (Table 4) .
It is reasonable to assume that, if the aforementioned fracture devices would produce enough force to create a fracture, they would also cause soft tissue damage. The same reasoning was applied to the ballistic fracture of Hill and Watkins (2001) . Petri and Schaberg (1984) mention creating soft tissue damage with a haemostat. This way, soft tissue damage is www.ecmjournal.org present in the same nineteen (25.3 %) studies that include the creation of a real fracture. None of the defect/osteotomy studies report creating additional soft tissue damage, beyond damage that is caused by the surgical dissection and creation of the defect/ osteotomy.
In thirty-five (46.7 %) studies osteosynthesis is achieved with a plate. Polyacetyl (n = 10; 28.6 %) (Brick et al., 2009; Brown et al., 2014; Chen et al., 2002; Chen et al., 2005; Chen et al., 2006; Chen et al., 2007; Guelcher et al., 2011; Sanchez et al., 2013; Tennent et al., 2016) , titanium (n = 7; 20 %) Rochford et al., 2016; Stewart et al., 2012; Windolf et al., 2013; Windolf et al., 2014; Xiao et al., 2015; Xie et al., 2009) and polyoxymethylene (n = 6; 17.1 %) (Penn-Barwell et al., 2012a; Penn-Barwell et al., 2012b; Penn-Barwell et al., 2014a; Penn-Barwell et al., 2014b; Penn-Barwell et al., 2015; Rand et al., 2015) are the most used materials. In thirty (40 %) models, the fracture is stabilised with an intramedullary nail. In two of these, external fixation is performed in addition to intramedullary fixation (Curtis et al., 1995; Hamel et al., 2008) . In small animals (rabbits and rats), k-wires serve as intramedullary fixation devices (n = 19; 63.3 %) (Bilgili et al., 2015; Boyce et al., 2012; Darouiche et al., 1998; Gilbert et al., 2015; Hamel et al., 2008; Hamza et al., 2012; Helbig et al., 2015; Lesic et al., 2004; Li et al., 2009; Lindsey et al., 2010a; Lindsey et al., 2010b; Prinz et al., 2017; Sener et al., 2010; Stewart et al., 2010; Worlock et al., 1988a; Worlock et al., 1988b; Worlock et al., 1994; Zhou et al., 2017) . In two studies, both plate fixation and intramedullary fixation are used, although not in the same animal (Arens et al., 2015; Worlock et al., 1994) . Evans et al. (1993) describe a model in which stability is achieved by means of screw 
Objective of research
Number of articles References
Model description 11
Alt Andriole et al., 1973; Arens et al., 2015; Azi et al., 2012; Chen et al., 2005; Helbig et al., 2015; Inzana et al., 2015; Passl et al., 1984; Robinson et al., 2011; Windolf et al., 2013; Worlock et al., 1988b Treatment 13 Bi Brown et al., 2000; Brown et al., 2014; Hamel et al., 2008; Huang et al., 2013; Khodaparast et al., 2003; Lubis et al., 2005; Penn-Barwell et al., 2014b; Petri and Schaberg, 1984; Rand et al., 2015; Sanchez et al., 2013; Sener et al., 2010 Prevention 29 Ter Boo et al., 2016; Boyce et al., 2012; Costa et al., 2016; Darouiche et al., 1998; Fei et al., 2010; Hill et al., 2002; Hill and Watkins, 2001; Jacob et al., 1993; Jacob et al., 1997; Lesic et al., 2004; Li et al., 2009; Lindsey et al., 2010a; Lovati et al., 2016a; Metsemakers et al., 2016; Penn-Barwell et al., 2012a; Penn-Barwell et al., 2012b; Penn-Barwell et al., 2015; Schaer et al., 2012; Sethi et al., 2015; Stewart et al., 2010; Stewart et al., 2012; Tennent et al., 2016; Windolf et al., 2014; Worlock et al., 1994; Xiao et al., 2015; Xie et al., 2009; Zheng et al., 2010; Zhou et al., 2017 Bone healing 9
Bilgili Brick et al., 2009; Chen et al., 2002; Chen et al., 2006; Chen et al., 2007; Deng et al., 2013; Lovati et al., 2016; Schindeler et al., 2015; Southwood et al., 2004 Pathogenesis osteosynthesis. In seven models, no osteosynthesis is performed (Azi et al., 2012; Bi et al., 2007; Deng et al., 2013; Hill and Watkins, 2001; Huang et al., 2013; Lubis et al., 2005; Petri and Schaberg, 1984) . In these models, surrounding muscles provide sufficient stability or an external cast is applied. Only five (6.4 %) articles display models that combines these three features of FRI: creation of a fracture, inclusion of soft tissue damage and a time gap between bacterial inoculation and treatment of the fracture. These models use the same general setup: Sprague-Dawley rats are anaesthetised, the hind leg is shaved and a fracture of the femur is created using a custom-made device. In two out of five articles a weight is dropped from a height of 153 mm producing an estimated force of 104.8 N Lindsey et al., 2010b) . For the remaining three models, this information is not provided (Boyce et al., 2012; Li et al., 2010b; Lindsey et al., 2010c) . After fracture creation, the leg is prepped for surgery and an incision on the dorsolateral surface of the femur is made. The rats are inoculated with 100 µL of a bacterial suspension containing 10 2 /0.1 mL Staphylococcus aureus (S. aureus). The fracture is left open for 1 h. Lastly, the fracture is stabilised by an intramedullary k-wire, the wound closed and the anaesthesia ended. Fig. 2 displays the distribution of pathogens used in the included articles. A large majority (n = 69; 92 %) of the included models are inoculated with S. aureus as the single infection-causing pathogen. In two of these, a methicillin-resistant S. aureus (MRSA) strain is used (Hamel et al., 2008; Xiao et al., 2015) . S. aureus is administered as an intracellular inoculum inside the osteoblasts in one study (Hamza et al., 2012) . ATCC 25923 (Fei et al., 2010; Prinz et al., 2017; Schaer et al., 2012; Sener et al., 2010; Southwood et al., 2004; Stewart et al., 2012; Tran et al., 2013; Xie et al., 2009; Zhou et al., 2017) and Xenogen 36 (Guelcher et al., 2011; Inzana et al., 2015; Penn-Barwell et al., 2012a; Penn-Barwell et al., 2012b Brown et al., 2014 Brown et al., et al., 2015 Rand et al., 2015) are the most commonly used strains (n = 9; 13 %). ATCC 29213 is utilised in five (7.2 %) studies (Curtis et al., 1995; Hill et al., 2002; Hill and Watkins, 2001; Windolf et al., 2013; Windolf et al., 2014) . In nine (13 %) animal models, a clinically isolated strain of S. aureus is introduced. The clinical strains are isolated from patients with chronic osteomyelitis (Boyce et al., 2012) , infected prosthesis (Chen et al., 2005; Robinson et al., 2011) , infected wound (Li et al., 2010b; Lindsey et al., 2010b; Lindsey et al., 2010c) , intra-articular infections (Bilgili et al., 2015) or blood (Hamel et al., 2008) . In one study, the clinical source is not specified (Chen et al., 2002) .
Pathogen characteristics
Other strains and multi-strain models are mentioned in less than five (7.2 %) studies each. Nine articles (13 %) do not specify the strain or source of S. aureus www.ecmjournal.org used in their setup (Azi et al., 2012; Brick et al., 2009; Brown et al., 2014; Chen et al., 2006; Chen et al., 2007; Deng et al., 2013; Hamza et al., 2012; Li et al., 2009; Xiao et al., 2015) . Four (5.3 %) models use a combination of S. aureus and another pathogen. The combination of S. aureus with Escherichia coli (E. coli) is described twice (Passl et al., 1984; Stewart et al., 2010) . Although, only in one of these studies a polymicrobial inoculum was used (Stewart et al., 2010) . The other two studies combine S. aureus with Acinetobacter baumannii (A. baumannii) (Gilbert et al., 2015) or Pseudomonas aeruginosa (P. aeruginosa) (Petri et al., 1984) in the same inoculum.
Including both inoculation alone or in combination with a second pathogen, S. aureus was used in 73 out of 75 (97.3 %) studies. Three models are inoculated with other species. Two use methicillin-resistant Staphylococcus epidermidis (S. epidermidis) (MRSE; strain GOI1153754-03-14) (Lovati et al., 2016a; Lovati et al., 2016b) and one use E. coli (Passl et al., 1984) .
Inoculation is accomplished in several different ways, e.g. the pathogen is applied to the collagen (Rand et al., 2015) , directly to the implant (Rochford et al., 2016) or injected using a saline solution (Lovati et al., 2016b) .
Discussion
A substantial amount of research is conducted aiming to improve our knowledge on FRIs and to develop novel interventional strategies to reduce the incidence and improve treatment outcome. New prevention and treatment concepts for human patients require preclinical testing, which includes animal studies. The model used need to be in line with current clinical problems (Brown et al., 2014) . Although the models of orthopaedic implant infection are reviewed by Calabro et al. (2013) and Reizner et al. (2014) , to the best of our knowledge, this is the first systematic review of its kind focusing solely on FRIs.
The hypothesis of the present study was that preclinical in vivo models only rarely mimic the real clinical situation and do not include key factors such as delay before treatment, presence of a fracture, soft tissue damage and diversity of causative pathogens.
Animal species
Most of the studies are performed using small animals such as rats, rabbits, mice and guinea pigs (n = 66; 88 %). Thus, large animals such as dogs, sheep, goats and pigs are only described in nine experimental setups (12 %) ( Table 2 ,3). To the best of our knowledge, there is currently no evidence on the effect of the animal choice on the study validity. However, it seems rational to base the choice of animal on the study objective. Large animals could be favoured in case of biomechanical studies, while small animals (e.g. rodents) are more suitable for the investigation of molecular mechanisms and genetics of bone healing (Auer et al., 2007) . Another element to keep in mind when selecting the animal species is the availability of the specific tools needed to produce some of the key characteristics of an FRI. Such tools are currently primarily available for mice, rats, rabbits and sheep. Since the inclusion of specific key factors of an FRI will likely have a bigger impact on the validity of the study than the selection of the animal, it makes sense to opt for one of these species, if possible.
Finally, utilising large animals could involve problems such as increased cost, additional space requirement and reduced availability of molecular biology tools in comparison with smaller animal (e.g. rodent) models.
Anatomical location
Most studies are performed using the lower limb (n = 65; 86.7 %). Instability is created in the upper limb in the remaining ten models (13.3 %) (Table 2-4). There is currently a lack of evidence suggesting one anatomical location is favoured over the others, however, the objective of the study should be kept in mind. For generic research on FRIs, the anatomical location will be of lesser importance. Although, when the research question is closely linked to soft tissue injury/coverage, this should be considered when choosing the optimal anatomical location.
Delay before treatment
In most models (n = 63; 84 %) (Table 2-4) the wound is closed immediately after the inoculation of the pathogen. This approach is not congruent with the clinical setting, because often a time gap exists between the occurrence of an open fracture, for example, and treatment commencing (e.g. transport to the hospital, diagnostic examinations). Current guidelines recommend fracture irrigation and debridement within the first 6 h after admittance. In the models described as open, the delay-totreatment is as little as 30 min. The influence of this time gap on infection rates is debated. Srour et al. (2015) demonstrate in a prospective study that the time to irrigation and debridement does not increase Preclinical models of FRI infection rates, provided it is performed within 24 h following the injury. In daily practice, these results could lead to even longer time lapses between the trauma and initial surgery (i.e. debridement and fixation), making the gap between clinical reality and translational research even bigger. Furthermore, in cases of chronic/late-onset FRI (i.e. fistulae), time to definitive treatment and concomitant soft tissue coverage is often even longer. Therefore, it seems imperative that future in vivo models take these time windows into account when developing new prevention and treatment technologies. Of course, the inclusion of a delay-to-treatment will also entail a risk for certain disadvantages. Increasing the time gap might increase variability in the infection (i.e. development of polymicrobial infections), which is compatible with the clinical setting, but the disadvantage would be to have a less controllable environment with respect to the infecting pathogens. Furthermore, it might also entail a longer anaesthesia time and, therefore, a greater burden on the animal.
Instability and fixation method
The second observation was that within the included studies, bony instability is often created by an osteotomy or a defect (double osteotomy). Although creating a real fracture is far more realistic, this method is only found in 25.3 % (n = 19) of the studies (Table 2 ). In these models, a fracture is mostly created using a device that drops a weight onto the bone. Compared to a clinical situation, fracture stability will be more difficult to achieve in case of a fracture as compared to a controlled osteotomy, which is often performed after the osteosynthesis. A fracture may be multi-fragmentary and associated with periosteal stripping, leading potentially to increased instability and vascular damage. Although creating an osteotomy improves reproducibility of the in vivo model and, in that way, keeps the number of animals used to a minimum, one could argue that there is a difference regarding the grade of stability when comparing an osteotomy and a fracture. As mechanical stability is crucial not only for fracture healing but also for infection prevention and treatment (Merritt and Dowd, 1987; Sabate Bresco et al., 2017) , it seems an important parameter to include in preclinical research. Furthermore, in small animals, fixation is often performed using an intramedullary k-wire (Bilgili et al., 2015; Boyce et al., 2012; Darouiche et al., 1998; Gilbert et al., 2015; Hamel et al., 2008; Hamza et al., 2012; Helbig et al., 2015; Lesic et al., 2004; Li et al., 2009; Lindsey et al., 2010a; Lindsey et al., 2010b; Prinz et al., 2017; Sener et al., 2010; Stewart et al., 2010; Worlock et al., 1988a; Worlock et al., 1988b; Worlock et al., 1994; Zhou et al., 2017) . This will negatively impact the stability as compared to a clinical setting where more stable fixation options, e.g. locking screws, are available. Rittmann and Perren (1974) , in an experimental study in sheep, show the positive effects of stability on infection in fracture care. They state that the advantage of the stabilising effect of an implant outweighs the disadvantage of a foreign body effect. Therefore, it seems important to keep in mind stability as a parameter when developing a model of an FRI, thereby focusing not only on the creation of bony instability, but also on the type of implant for fixation.
Optimally, future research should include standardised mechanical design strategies to carefully control and describe stabilisation of the construct. This would improve our ability to compare the outcome of different studies.
Soft tissue damage
A third observation was that only a minority of studies mimic soft tissue injuries (n = 19; 25.3 %) ( Table 2) . These are, for the most part, also the studies where a device creates a fracture, as previously mentioned. By performing an osteotomy or creating a defect, soft tissue damage is limited to the incision and dissection needed during the surgical procedure. This does not really correspond to daily clinical practice, where fractures are often accompanied by extensive soft tissue damage, potentially causing vascular compromise or the development of haematomas. Soft tissue damage is actually one of the most important factors that influences the risk of infection (Kalicke et al., 2003; Kortram et al., 2017) . For example, despite the use of systemic antibiotics, open fractures still have higher infection rates as compared to closed fractures. A reason for this is that necrotic tissue often serves as a breeding ground for bacteria that can sustain the infection. Another possible explanation is that systemic antibiotics may not reach the tissueimplant interface in high enough concentrations to eradicate bacteria due to local vascular damage. Furthermore, in cases of an FRI there is also, often, soft tissue damage (e.g. draining wounds, fistulae) (Metsemakers et al., 2018b) . Therefore, translating results from preclinical in vivo work regarding, for example, new local antibiotic-delivery devices for FRI prevention or treatment should be undertaken with caution when soft tissue damage is not included.
Pathogen characteristics
97.3 % (n = 73) of the 75 included models reviewed used S. aureus as the infection-causative microorganism. This might be explained by the fact that S. aureus is the most common single disease-causing pathogen in clinical FRIs (Torbert et al., 2015) . Nonetheless, the dominance is not reflective of the clinical scenario. Although the published literature confirms that S. aureus is the most common disease-causing pathogen, it is responsible for only 30 % of all FRIs, which is comparable to the prevalence of polymicrobial infections (27 %) and coagulasenegative staphylococci (CoNS), such as S. epidermidis (22 %). Other organisms, such as Gram-negative bacilli, are responsible for the remaining 10 % www.ecmjournal.org (Trampuz and Zimmerli, 2006) , but are only studied (i.e. E. coli) as a single pathogen or in combination with S. aureus in two of the models (Passl et al., 1984; Stewart et al., 2010) . S. epidermidis can be found in only two (2.6 %) animal models, despite this microorganism having an important clinical impact due to its prevalence and widespread antimicrobial resistance (Morgenstern et al., 2016a; Morgenstern et al., 2016b) . Therefore, the focus on S. aureus is understandable, but a gap of knowledge remains with regards to other pathogens in FRIs and preclinical models are not yet available to address this problem.
CFU count
The order of magnitude of the amount of inoculated bacteria varies between 1 (Costa et al., 2016) and 10 10 CFU . Arens et al. (2015) determine that the minimum CFU count needed to reliably cause an infection in their rabbit humeral osteotomy model is 6 × 10 6 . This will likely be the optimal dose to be used in future research. However, the appropriate dose will vary depending on different parameters, such as animal selection, pathogen and implant and cannot be taken as a general inoculation guide.
General considerations and conclusion
Overall, only five (6.7 %) studies include a model that combines all key features of an FRI in one model: the presence of a fracture, delay before treatment and soft tissue damage (Boyce et al., 2012; Li et al., 2009; Li et al., 2010b; Lindsey et al., 2010b; Lindsey et al., 2010c) . Although these studies only use S. aureus, they remain the models most closely recapitulating an FRI.
From an ethical standpoint it is difficult to include all the clinically important parameters in all preclinical studies. Including factors such as timing (i.e. leaving the wound open) and trauma severity (i.e. creation of a real fracture with soft tissue injury), for example, increases the burden upon the animal. Therefore, permission from an ethical approval body for such models could be more difficult to obtain. Keeping in mind that animal care is of the highest importance, interventions should be taken to minimise the load put on the animal. This could be achieved by following the 3R principles first described by Russel and Burch (1959) . Since studies have failed to develop an experimental setup that could serve as a viable alternative to animal models for the research on fractures and FRIs (Auer et al., 2007) , the emphasis should be placed on refinement of models that are currently being used and reducing the number of animals that is needed to obtain a comparable level of information. Refinement of current models entails the development and application of standardised anaesthesiology and pain management protocols. Adequate analgesic therapy not only reduces the burden upon the animal but might also improve the validity of the experiment (Auer et al., 2007) . A reduction in the number of animals that is needed to attain an equal amount of data might be achieved by optimising the experimental setup. Nonetheless, it is difficult to define the ideal preclinical model. Hooijmans et al. (2018) adapt the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach (Atkins et al., 2005) for the appraisal of preclinical models. They propose a set of steps to evaluate the certainty in the evidence from preclinical animal studies. One of these steps evaluates the similarities between the described animal model and the clinical setting. Therefore, the model is compared to the research question: does the experimental setup adequately reflect the population, intervention and comparison? It seems logical that matching these populations as closely as possible (i.e. will the intervention eventually be applied in open fractures with soft tissue damage? Will a time gap be present?) will only improve the validity of the model. Thus, for animal models that should mimic the clinical setting as closely as possible, the implementation of four key characteristics is proposed: creating instability by performing a true fracture, establishing soft tissue damage, implementing a delay-to-treatment and using a pathogenic profile that approaches the clinical reality. However, not all fractures in daily clinical practice present severe soft tissue damage and certainly not all fractures are open fractures. The implementation of all the aforementioned characteristics may only be required for new strategies that are close to clinical implementation or for research questions that are likely influenced by these factors. Early stage innovations may be adequately evaluated in 'simpler' models, with comparatively less burden upon the animal, only moving to the more 'complex' models as the development cycle nears completion. Overall this means that preclinical studies should consider including parameters (e.g. soft tissue damage) that seem clinically important when focusing on prevention and treatment of FRIs without compromising the care for the animal.
In conclusion, this review demonstrated that preclinical in vivo studies rarely recreate a model of FRI that mimics all aspects of the clinical setting with creation of a fracture in combination with softtissue injury. In addition to S. aureus, the application of other clinically important pathogens and even polymicrobial infections should be considered. To really make progress in the field of prevention and treatment of FRIs, existing preclinical models should be adapted or research experts should consider developing new models to better match clinical scenarios. (Auer et al., 2007) . Biology is a factor but, currently, the immune response to FRIs in the different animal species is only poorly understood. Within this respect, mice might be the best understood species, but this certainly does not mean that they are the closest resemblance to humans. Additionally, cost will have a large impact, which favours the use of smaller animals.
To increase the value of the research, models using both small and large animals should include the key characteristics of an FRI: a real fracture, soft tissue damage, a time gap and a diversity in pathogens.
Currently, the specific tools to produce some of these key characteristics are mainly available for mice, rats, rabbits and sheep. Thus, all these species are good options for future research.
The appropriate mechanism of injury is presumably the creation of a traumatic fracture. This could, for example, be done by means of dropping a weight. In addition to creating a more realistic fracture, this type of injury will also incorporate soft tissue damage.
Stephen Kates: What about the closed fracture that is opened for surgical repair and becomes infected? Authors: Clinically, the risk of infection after closed fractures is less frequent as compared to open fractures, but it would also be an interesting study topic. Theoretically, these infections are seeded at the time of (or shortly after) the primary surgical procedure. Therefore, preclinical models studying these infections will require inoculation at the time of surgery or with a short delay. The used pathogen should be selected based on the clinical scenario that aims at reproducing. However, soft tissue damage can be limited and there is no need for a time gap between injury and treatment, which will make these models also less of a burden for the experimental animals.
Volker Alt: Would you prefer an osteotomy or a fracture model for preclinical testing? Authors: When choosing between these two models, two factors should be considered. Since fracture stability influences infection, the chosen model should ideally mimic daily clinical practice. In clinical practice adequate fixation is harder to achieve in case of a fracture as compared to the use of an osteotomy. On the other hand, instability should be reproducible when applied to multiple animals. This is of course easier in case of an osteotomy. Therefore, in theory, the optimal method would be a reproducible fracture model, which is currently difficult to achieve.
Volker Alt: Which microorganisms and, in case of polymicrobial approaches, which combinations should be used more often besides S. aureus in FRI models? Authors: Preclinical models should reflect the diversity in pathogens found in a clinical setting. Trampuz and Zimmerli (2006) display the heterogeneity of infection-causing pathogens. While S. aureus is still responsible for a substantial part of all infections, researchers should not solely focus on this microorganism. Instead, they should consider other bacteria that have a nearly similar share in causing FRIs. Several studies show the important contribution of S. epidermidis (Sabate Bresco et al., 2017; Trampuz and Zimmerli, 2006) . However, this fact is currently not reflected in research setups. In addition, considering the recent increase in infections caused by multidrug-resistant germs, these should also play a vital role in modern study setups.
The appropriate combinations of microorganisms for the research on polymicrobial approaches are more difficult to define, since evidence concerning this subject is limited. Available clinical studies show that the following bacterial species are often involved in polymicrobial infections: S. aureus, P. aeruginosa, A. baumannii and Enterococcus species (Jorge et al., 2018, additional reference) .
Volker Alt: What is the objective benefit of FRI models including all 3 key features of open fractures? In other words: is there experimental evidence to adapt preclinical models to clinical FRIs by delay before treatment and tissue damage, especially behind the background of the 3R principles? Authors: Separate independent studies show that each of these key features individually impact the infection (Kalicke et al., 2003; Kortram et al., 2017; Worlock et al., 1994) . In clinical cases, all of these factors are often present. One of the proposed grading scales to evaluate the adequacy of an experimental setup is the modified GRADE scale (Hooijmans et al., 2018) . In one of the steps of this scale, the comparability between the animal model and the research question is examined. Therefore, matching the experimental setup as closely as possible to the clinical setup, by implementing these features, would increase the value of the gathered evidence from these models.
David Grainger:
Can the authors comment about the experimental approaches to produce polymicrobial infections in these preclinical models, as they might be more comparable to clinical FRIs? What are the best practices? Authors: Only three (4 %) of the 75 studies that were included in this systematic review describe a model in which a polymicrobial infection is studied. This number is very low in comparison to the 27 % occurrence of polymicrobial infections in a clinical setting (Trampuz and Zimmerli, 2006 ), suggesting further study on polymicrobial infection is warranted.
